Chengdu Olymvax Biopharmaceuticals, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 80.34% vs 23.59% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 488.57% vs 74.36% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "157.80",
          "val2": "87.50",
          "chgp": "80.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.50",
          "val2": "2.30",
          "chgp": "1,313.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.10",
          "val2": "3.70",
          "chgp": "10.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "27.20",
          "val2": "-7.00",
          "chgp": "488.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "205.80%",
          "val2": "-89.90%",
          "chgp": "29.57%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 19.42% vs 18.83% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 39.49% vs 37.72% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "701.50",
          "val2": "587.40",
          "chgp": "19.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "76.00",
          "val2": "57.40",
          "chgp": "32.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.10",
          "val2": "14.50",
          "chgp": "4.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "21.90",
          "val2": "15.70",
          "chgp": "39.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "46.90%",
          "val2": "36.50%",
          "chgp": "1.04%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

157.80

87.50

80.34%

Operating Profit (PBDIT) excl Other Income

32.50

2.30

1,313.04%

Interest

4.10

3.70

10.81%

Exceptional Items

0.00

0.00

Consolidate Net Profit

27.20

-7.00

488.57%

Operating Profit Margin (Excl OI)

205.80%

-89.90%

29.57%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 80.34% vs 23.59% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 488.57% vs 74.36% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

701.50

587.40

19.42%

Operating Profit (PBDIT) excl Other Income

76.00

57.40

32.40%

Interest

15.10

14.50

4.14%

Exceptional Items

0.00

0.00

Consolidate Net Profit

21.90

15.70

39.49%

Operating Profit Margin (Excl OI)

46.90%

36.50%

1.04%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 19.42% vs 18.83% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 39.49% vs 37.72% in Dec 2024

All Annual Results